MiRNA-based therapy for cancer: MiRNA-139-5p suppresses the expression of RNA polymerase III via down regulation of its target gene, 07/March/2015, 15.59

Natural product-based therapy for Metastatic tumors: BRCA1 decreases the expression of PD-1, a suppressor of activation of T-cells, and activates the immune system via down regulation of its target gene, 7/March/2015, 15.56
March 7, 2015
Interleukin-based anti-cancer therapy: Interleukin-37 (IL-37) increases the expression of CCM/KRITI via down regulation of its target gene, 07/March/2015, 16.02
March 7, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for cancer: MiRNA-139-5p suppresses the expression of RNA polymerase III via down regulation of its target gene, 07/March/2015, 15.59, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Amount: $ 300

Undisclosed information: How MiRNA-139-5p suppresses the expression of RNA polymerase III

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.